US Broker Ratings

Enovis Corporation (ENOV) Stock Analysis: Exploring a Healthcare Investment with 100% Upside Potential

Enovis Corporation (NYSE: ENOV) offers an intriguing opportunity for investors seeking exposure to the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.3 billion, this..

CG Oncology, Inc. (CGON) Stock Analysis: A Biotech Gem with 48.62% Upside Potential

In the fast-evolving world of biotechnology, CG Oncology, Inc. (NASDAQ: CGON) is capturing investor attention with its promising pipeline of bladder cancer therapeutics. With a robust market capitalization of $4.4..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating Volatility with a 5.03% Dividend Yield

DENTSPLY SIRONA Inc. (XRAY) stands as a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry. With its headquarters in Charlotte, North Carolina, the company..

Mirum Pharmaceuticals, Inc. (MIRM): A Promising Biotech Play with a 12.88% Upside Potential

For investors keeping a close watch on the biotechnology sector, Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) presents a compelling opportunity. With a robust market capitalization of $5.01 billion, this U.S.-based biopharmaceutical..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a 45% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a key player in the biotechnology industry, holds a promising position in the healthcare sector with its focus on developing treatments for rare diseases. With..

Perrigo Company plc (PRGO): Investor Outlook Reveals a Potential 45.83% Upside

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector, is making waves with a potential upside of 45.83% as suggested by its average target price. Headquartered in..

Zai Lab Limited (ZLAB) Stock Analysis: Eyeing a 169% Potential Upside in the Biotech Arena

Zai Lab Limited (NASDAQ: ZLAB) has emerged as a significant player in the biotech sector, with a focus on pioneering therapies in oncology, immunology, neuroscience, and infectious diseases. Based in..

Merus N.V. (MRUS) Stock Analysis: Exploring the Potential 7.78% Upside in the Biotech Sector

Merus N.V. (MRUS), a prominent player in the biotechnology sector, operates from the Netherlands with a keen focus on developing innovative antibody therapeutics. Although Merus is currently a clinical-stage company,..

Privia Health Group, Inc. (PRVA) Stock Analysis: A Healthcare Innovator with 29.67% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) is generating buzz in the healthcare sector as a promising player in the health information services industry. Based in Arlington, Virginia, Privia Health is..

Concentra Group Holdings Parent (CON) Stock Analysis: A Healthcare Play with a 28% Upside Potential

Investors with a keen eye on the healthcare sector may find Concentra Group Holdings Parent (NASDAQ: CON) an intriguing opportunity. With its robust presence in the medical care facilities industry,..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 31% Potential Upside in Neurological Innovations

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a pioneering force in the biotechnology sector, is drawing considerable attention from investors due to its focused efforts on developing treatments for neurological and psychiatric..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unpacking the 52.71% Potential Upside for Investors

CRISPR Therapeutics AG (NASDAQ: CRSP), a leader in the biotechnology sector, is making headlines with its promising gene-editing technologies. With an impressive market cap of $5.21 billion, this Swiss-based company..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 34.56% Upside Potential in the Medical Devices Sector

Haemonetics Corporation (NYSE: HAE), a Boston-based innovator in medical technology, is capturing the attention of investors with its robust portfolio of healthcare solutions. The company’s strategic focus on automated plasma..

Metsera, Inc. (MTSR) Stock Analysis: Navigating the Uncharted Waters of a Clinical-Stage Biotech

Investors intrigued by the high-risk, high-reward nature of biotechnology stocks may find Metsera, Inc. (MTSR) an interesting case study. As a clinical-stage biotech company operating under the umbrella of Pfizer..

QuidelOrtho Corporation (QDEL) Investor Outlook: Analyzing a Potential 33.66% Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL) is a prominent player in the healthcare sector, specializing in medical devices, particularly diagnostic testing solutions. With a market capitalization of $1.95 billion, this U.S.-based company..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Exploring a 56.89% Upside Potential

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands out in the biotechnology sector with a market capitalization of $2.78 billion. As a player in the healthcare industry, Apellis is focused on addressing..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Unveiling a Potential 60.89% Upside with Innovative Endocrine Solutions

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), headquartered in San Diego, California, stands as a beacon in the biotechnology sector, focusing on novel therapeutics for rare endocrine diseases and related tumors. With..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 51.55% Upside Potential in the Biotech Sector

Immunovant, Inc. (IMVT), a prominent player in the biotechnology sector, has captured the attention of investors with its clinical-stage developments targeting autoimmune diseases. The New York-based company focuses on innovative..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Biotechnology Innovator with 12% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out in the biotechnology sector with its innovative approach to treating serious diseases through targeted protein growth factor therapies. The Massachusetts-based company has..

PROCEPT BioRobotics (PRCT): A Robotics Innovator with a 71% Potential Upside

For investors with a keen eye on the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents an intriguing prospect. Specializing in medical devices, this San Jose-based company is at the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds